Flow Traders U.S.’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-17,255
Closed -$1K – 1171
2023
Q2
$1K Buy
17,255
+6,850
+66% +$465 ﹤0.01% 803
2023
Q1
$1K Buy
+10,405
New +$918 ﹤0.01% 838

Other funds holding TLSIW

Flow Traders U.S.'s TLSIW Position: Q3 2023 in Review

Flow Traders U.S. sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2023, closing a stake of 17,255 shares — an estimated $1K sold.

Flow Traders U.S. first reported a position in TLSIW in Q1 2023 and held it in 2 quarters. The position peaked at $1K in Q2 2023. 19 funds tracked by Wall St. Rank hold TLSIW as of Q3 2023.

  • Flow Traders U.S. reported no remaining TriSalus Life Sciences Warrant position as of Q3 2023 after selling out during the quarter.
  • Flow Traders U.S. sold 17,255 TriSalus Life Sciences Warrant shares in Q3 2023, an estimated $1K.
  • Flow Traders U.S. first reported a position in TriSalus Life Sciences Warrant in Q1 2023 and held it in 2 quarters.
  • Flow Traders U.S.'s TriSalus Life Sciences Warrant position peaked at $1K in Q2 2023.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2023.

Based on Flow Traders U.S.'s 13F filing for Q3 2023, filed 14 Nov 2023.